Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Glimvea-M 1 Tablet

Prescription Icon
Prescription Required

Marketer

Craveon Lifesciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimvea-M 1 Tablet

DiaBeta-Duo, a dual-action antidiabetic medication, is prescribed for adult patients with type 2 diabetes. This formulation effectively manages blood glucose levels. Always ingest DiaBeta-Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. DiaBeta-Duo is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential to mitigate this risk. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. DiaBeta-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to evaluate blood cell counts and liver function, will be necessary.

Uses of Glimvea-M 1 Tablet

Managing Type 2 Diabetes

Major Benefits of Glimvea-M 1 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take one Glimvea-M tablet with a meal.

Common Side effects of Glimvea-M 1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimvea-M 1 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take one Glimvea-M tablet with a meal.

How Glimvea-M 1 Tablet works:

Glimvea-M, a single tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimvea-M 1 Tablet and alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimvea-M 1 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Glimvea-M 1 Tablet is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimvea-M 1 Tablet cautiously, potentially requiring dosage modification under medical supervision. Glimvea-M 1 Tablet is contraindicated in those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimvea-M 1 Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, Glimvea-M 1 Tablet is typically initiated at a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimvea-M 1 Tablet :

Should you forget to take a Glimvea-M 1 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimvea-M 1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimvea-M 1 Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimvea-M 1 Tablet can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimvea-M 1 Tablet and seek immediate medical attention.
Glimvea-M 1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimvea-M 1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimvea-M 1 Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental Vitamin B12 is recommended by some researchers.
Glimvea-M 1 Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimvea-M 1 Tablet with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and may also increase the risk of lactic acidosis.
Glimvea-M 1 Tablet
57
MRP 69
17% off